In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, CTOs, VPs of Product Development, heads of regulatory affairs, and commercial directors from companies that manufacture neuroimaging devices, neuromarketing solutions, EEG/fMRI equipment OEMs, and biometric technology developers were examples of supply-side sources. Chief marketing officers, directors of consumer insights, brand strategists, and research heads from Fortune 500 consumer packaged goods businesses, advertising agencies, market research organizations, and user experience (UX) research departments were among the demand-side sources. Primary research confirmed product development timelines for AI-integrated neuromarketing platforms, validated market segmentation across neuroscience research, clinical diagnostics, therapeutic applications, and advertising optimization use cases, and gathered information on pricing models for SaaS-based neuromarketing analytics, ethical framework compliance costs, and obstacles to technology adoption.
Primary Respondent Breakdown:
By Designation: C-level Primaries (42%), Director Level (25%), Others (33%)
By Region: North America (40%), Europe (25%), Asia-Pacific (28%), Rest of World (7%)